5th Annual Product Lifecycle Management (2012) Pp


Published on

Email piyush.patel@visiongain.com for early bird discount

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

5th Annual Product Lifecycle Management (2012) Pp

  1. 1. 5th Pharmaceutical Product Lifecycle Management An integrated advance towards pharmaceutical product lifecycle management optimisation 24th - 25th January 2012, Visiongain Conference Centre, London, UK BOOK NOW! Key Speakers Dr Jonathan Deutsch, Safety Science Leader, Roche Dr Beverley Forsythe, Principal Safety Physician, AstraZeneca Christiano Silva, Global Product Manager, Boehringer-Ingelheim Dr Denise Oleske, Director of Pharmacoepidemiology & Global Surveillance, Abbott Oliver Mitchell, Head of Customer Excellence, Abbott Bill Griffiths, DVP, Regulatory Affairs, Abbott Dr Enrica Alteri, Head Risk Management & Epidemiology, Merck Serono Dr Miri Halperin, Global Head of Business Affairs, Actelion Pharmaceuticals Hans Hoogkamer, Global Business Affairs, Actelion Pharmaceuticals Garreth Duncan, Associate, D Young & Co Professor Johanna Gibson, Intellectual Property Law, Queen Mary, University of London Dr Afzal Mohammed, Lecturer in Pharmaceutics, Aston University Professor Howard Stevens, Professor of Exploratory Drug Delivery, University of Strathclyde John Bennett, Consultant, Harpum Consulting Paul Fitzgerald, Director, Syntropy Medica Driving the Industry Forward | www.futurepharmaus.comMedia Partners Organised By To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/plm
  2. 2. Conference Introduction 5th Pharmaceutical Product Lifecycle Management 24th - 25th January 2012, London, UK Dear Colleague, Media Partners: esearch shows that pharmaceutical companies spend approximately 19% of their total R PharmiWeb.com is the leading industry-sponsored portal for revenue on activities that fall under the heading of pharmaceutical lifecycle management the pharmaceutical sector. Supported by most of the leading (PLM)1. With many blockbuster drugs drawing closer to the end of their patents, R&D new pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, chemical entity output declining and the current economic climate; the utilisation of product features, events listings and international jobs to industry professionals across Europe lifecycle management is set to increase as pharmaceutical companies look for ways to and the US. optimise revenue. For further information please email: corporate@pharmiweb.com oin us at Visiongain’s 5th Pharmaceutical Product Lifecycle Management Conference J BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY where you will obtain up-to-date practical knowledge on PLM encompassing an array of WORLD. It is based and located in Warsaw, Poland. issues ranging from drug portfolio management, patent protection, regulation, submission Biotechnology World was founded in 2007 to provide the world’s biotech and pharma and drug safety. In a period when PLM is increasing in popularity and importance, we aim information and market to make it universally accessible and useful for scientific to provide applicable case studies as well as a focus on topical PLM strategies such as and business processes. Its first step to fulfilling that mission was building the Reformulation and Brand Optimisation. BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in o not miss this exciting opportunity to further your knowledge in an interactive learning D different channels. BIOTECHNOLOGY EUROPE offers companies completed internet environment while networking with diverse leaders in the PLM sector! public relations, publication and marketing solutions. One of the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to Reasons to register today: global biotechnology, pharmaceutical and life science activities. For further information please visit: www.biotechnology-europe.com • Gain integrated insight of the entire process of PLM. Driving the Industry Forward | www.futurepharmaus.com Future Pharmaceuticals has forged powerful relationships • Learn about patent protection strategies. with key industry leaders to provide a platform for successful • Investigate improving the selection of drug candidates brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an • Analyse challenges involved with increasingly complex regulation and submissions authoritative resource within top pharma companies as well as small, specialty, and • Evaluate drug safety throughout PLM biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries’ • Optimise introduction, growth and maturity phases in PLM. top issues and the solutions top-tier vendors can provide. • Focus on brand optimising as a PLM strategy For further information please visit: www.futurepharmaus.com • Analyse the reformulation strategy of PLM InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is • Network with key leaders in the industry and take advantage of the learning platform home to InPharmjobs.com, Pharmafile and Pharmafocus. I look forward to meeting you at the conference For further information please visit: www.In-Pharm.com Best regards Poster Presentation At a busy conference it is hard to make sure everyone who shares your interests knows what you are doing. Maximise your time at Visiongain’s 5th Annual Pranita Nangia Pharmaceutical Product Lifecycle Management meeting by sharing your results in a Head of Conferences poster presentation. With a plethora of key decision makers, take advantage of this senior networking opportunity. Please send your 200 word abstract, in English, to: info@visiongainglobal.com for approval. The deadline for submissions is Tuesday 17th January, 2012. Please include contact details for the corresponding author(s). Who should attend? Academic institutions will not be charged a fee if booked as full-price delegates. Posters submitted by pharmaceutical and biotechnology firms will be charged a fee Presidents, CEOs, Vice-Presidents, CSOs, Directors, Senior Business Developers, of £199. Researchers, Consultants and Professors in: Posters submitted by service providers / vendors are welcome and will be subject • Product Lifecycle Management to evaluation. Upon approval a fee of £500 will apply. Two delegates from your organisation must be booked at full price to present a poster. • Portfolio Management Please note that all posters will be displayed at the discretion of Visiongain Ltd and • Research & development are subject to approval. Due to limited space, please register your interest early. • Business Development • Strategic Planning • Licensing Sponsorship and exhibition opportunities • Mergers & Acquisitions This event offers a unique opportunity to meet and do business with some of the key players in the pharmaceutical and biotech industries. If you have • Process Chemistry a service or product to promote, you can do so at this event by: • Formulation • Hosting a networking drinks reception • Brand Management • Taking an exhibition space at the conference • Advertising in the delegate documentation pack • Clinical Research • Providing branded bags, pens, gifts, etc. • Patent Law If you would like more information on the range of sponsorship or • Patent Counsel exhibition possibilities for visiongains 5th Annual Pharmaceutical Product Lifecycle Management Conference, please contact us: • Regulatory Affairs Piyush Patel, +44 (0)20 7549 9961 • Drug Development piyush.patel@visiongainglobal.comVisiongain Pharmaceutical Product Lifecycle Management 2010-2020 1
  3. 3. Day 1 5th Pharmaceutical Product Lifecycle Management Tuesday 24th January 2012 09:00 Registration and refreshments 12:40 Networking lunch 13.40 Drug safety in early development 09:30 Opening address from the Chair  • mportance of understanding mechanism of a new drug I  • voiding drug recall A 09:40 Innovative lifecycle and portfolio management  • xamples E strategies: create value for patients and pharma Dr Jonathan Deutsch Safety Science Leader  • ifecycle and portfolio management: how do they really create value? L Roche  • hy science is an important driver of corporate strategy W  • ow can innovation in science and corporate strategy be linked? H 14:20 Managing drug safety throughout product pipeline  • fficient portfolio planning in a resource constrained environment E and lifecycle Dr Miri Halperin Wernli & Hans Hoogkamer • Integrating signal detection using totality of information Global Business and Science Affairs • Implementing proactive safety risk management Actelion Pharmaceuticals • Understanding benefit-risk assessment and decision making • est practices for developing transparency with safety B governance committees 10:20 Benefit-risk evaluation throughout a drug’s lifecycle: a paradigm shift Dr Beverley Forsythe Principal Safety Physician  • mpact of the new pharma legislation: is the industry ready? I AstraZeneca  • he technical challenges: an overview of methodologies T  • ighlights of the PROTECT project H 15:00 Afternoon refreshments  • ow proactively managing safety during a product’s life cycle could be a H competitive advantage Dr Enrica Alteri 15:20 Sponsor Spotlight Session Head Risk Management & Epidemiology  T ake this unique opportunity to be a part of the conference theme, network, Merck Serono share ideas and provide an overview of your product/services to the audience. For more information please contact piyush.patel@visiongainglobal.com 11:00 Morning refreshments 16:00 Epidemiology for Maximizing Drug Safety throughout the Product Life Cycle 11:20 Strategies for maximising IP protection • Why is epidemiology essential throughout a drug’s life cycle?  • econdary patent strategies S • Electronic health databases and drug safety assessment  • atent term extension strategies P • ase study: Pharmacoepidemiological Safety Assessment of an C  • ata exclusivity and other regulatory protection D Anti-Obesity Drug Garreth Duncan • The future of epidemiology in drug safety assessment Associate Dr Denise Oleske D Young & Co Director of Pharmacoepidemiology & Global Surveillance Abbott 12:00 Presentation to be announced 16:40 Closing remarks from the Chair Professor Johanna Gibson Professor of Intellectual Property Law Queen Mary, University of London 16:50 Networking drinks Take your discussions further and build new relationships in a relaxed and informal setting Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011
  4. 4. Day 2 5th Pharmaceutical Product Lifecycle Management Wednesday 25th January 201209:00 Registration and refreshments 12:40 Networking lunch09:30 Opening address from the Chair 13:40 Electronic submissions: regulatory perpspective  • pdate on electronic submissions U09:40 Maximising introduction, growth, and maturity phases to increase revenue  • se of eCTD U • mportance of an early engagement with opinion leaders I  • ase study C • roduct uniqueness as trigger to revenue maximization throughout LCM P Remco Munnik RPN Regulatory  • linical development plan to support LCM: importance of choices C Pharma Net • aking market access and reimbursement strategies into consideration T Dr Christiano Pereira Silva 14:20 Brand extension into Emerging Markets Global Marketing Boehringer Ingelheim  • merging Markets – strategic opportunity but a crowded market E  • ross functional organisational considerations C10:20 Portfolio Management: crucial areas  • oordinated regulatory, commercial, development & manufacturing C • he varying requirements for industry T strategies • rug discovery and development phases D  • ld products for new markets O • arket access and commercial route of new drugs M Bill Griffiths DVP, Regulatory Affairs  • ffective resource optimisation. E Abbott John Bennett Consultant Harpum consulting 15:00 Afternoon refreshments11:00 Morning refreshments 15:20 Reformulation: the drug delivery perspective  • verview of reformulation O11:20 Brand optimisation  • mproving therapeutic effect with a change in drug delivery I • ist things first – portfolio optimisation F  • rug delivery options D • nderstanding the patient flow U  • xamples of cases of reformulation E • inking the strategy to the investment L Dr Afzal Mohammed • hy competitive analysis is so important W Lecturer in Pharmaceutics  • ow to create good marketing objectives H Aston University • ow to look at ROI H Ollie Mitchell 16:00 The contribution to PLM through academic Head of Customer Excellence spin-out activities Abbott  • TC field O  • eneric pharmaceutical field G12:00 Brand leverage methodologies  • P protected drug delivery systems I • verview O Professor Howard Stevens • reparing the product P Professor of Exploratory Drug Delivery  • efining the brand D University of Strathclyde • esources R • xamples E 16:40 Chair’s closing remarks Paul Fitzgerald Director Syntropy Medica 16:50 End of Conference
  5. 5. Registration Form 5th Pharmaceutical Product Lifecycle Management 24th - 25th January 2012, London, UK Angel Conf. code PP Pentonville Road 5th Pharmaceutical Product CiStandard Prices ty Lifecycle Management Ro adConference only Fee: £1299 VAT: £259.80 Total: £1558.80 24th - 25th January 2012 Old StreetNumber of bookings: Total cost: Location: Visiongain Conference Centre Old Street Address: 230 City RoadPromotional Literature Distribution City Road LondonDistribution of your company’s promotional literature to all conference attendees EC1V 2TT UK Fee: £999 VAT: £199.80 Total: £1198.80Details How to bookForename: Surname: Email: piyush.patel@visiongain.com Web: http://www.visiongain.com/plm Job Title: Company: UK Office: Tel: +44(0) 20 7549 9961 Fax: +44(0) 20 7549 9932 Main Switchboard Number: Visiongain Ltd BSG HouseAddress: 226-236 City Road London EC1V 2QY UKCountry: Postcode: General information Venue: Venue: Directions: Visiongain Conference Centre 230 City Road, London, EC1V 2TT. United Phone: Fax: Kingdom. Closest tube station is Old Street (Northern Line). Accommodation: Thistle City Barbican, Central Street, Clerkenwell, London, EC1V 8DS, Phone: 0871 376 9004 / +44 845 305 8304, Fax: 0871 376 9104 / +44 845 305 8343Email: http://www.thistle.com/en/hotels/united_kingdom/london/thistle_city_barbican/index.html Travelodge London City Road Hotel, 7-12 City Road, London, EC1Y 1AE, Tel: 0871 984 6333, Fax: 0207 Signature: 628 2503, http://www.travelodge.co.uk/search_and_book/hotel_overview.php?hotel_id=340 Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain I confirm that I have read and agree to the terms and conditions of booking Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the right to charge interest on unpaid invoices.Methods of payment Substitutions/name changes or cancellations: There is a 50% liability on all bookings once Payment must be made in sterling made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or after one month before the start of the event. Should you decide to cancel after this date, the full invoice By Mail: Complete and return your signed registration form together with your cheque payable must be paid. Conference notes will then be sent to you. Unfortunately, we are unable to transfer places to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK between conferences. However, if you cannot attend the conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and By Fax: Complete and fax your signed registration form with your credit card details substitutions must be from the same company or organisation and are not transferable between countries. Please note that discounted delegates places at a visiongain event are non refundable.to +44 (0) 20 7549 9932 Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details excluding substitutions/name changes, requested by the customer. This will be charged to the customer by credit card prior to the changes being made.By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive By Bank Transfer: briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try Visiongain Ltd A/C: visiongain Ltd to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or Barclays Bank Sort Code: 20-71-64 cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the Piccadilly Branch Account No: 6038 7118 cost of the registration, travel and expenses.48 Regent Street Swift Code: BARC GB22 Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data London, W1B 5RA IBAN: GB80 BARC 20716460387118 Protection Act 1988. Your personal information contained in this form may be used to update you on visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We Please debit my credit card: may also share your data with external companies offering complementary products or services. If you wish for your details to be amended, suppressed or not passed on to any external third party, please Access MasterCard Visa American Express send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details. Please allow approximately 30 days for your removal or update request to be applied to our database. Following your removal or update request, you may receive additional pieces of communication from Card number: visiongain Ltd during the transitional period, whilst the changes are coming into effect. Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly Expiry Date: recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT Security number (last 3 digits on back of credit card): incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com. Eurocash specialise in recovering cross-border VAT.Signature: How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you.Cardholder’s name: Unable to attend Obviously nothing compares to being there but you need not miss out. Simply tick the box and send News updates with your payment. You will receive speaker talks in PDFs two weeks after the event.Please tick if you do not want to receive email news updates in the future Yes, please send me speaker talks Price£550 VAT:£110 Total:£660 www.visiongain.com/plm